LT-V11

N/A

Report date: 2025/03/18 14:44:52

Base Information

Drug NameLT-V11
Drug Alias NameHepatitis B virus TCR T-cell therapy(Lion TCR)LT-V11LT V11
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicityHepatitis B virus inhibitors
TargetsHepatitis B virus
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLion Tcr Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLion Tcr Pte Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A